Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signalingR. P. Tripathi, Rina Plattner, Christina Meeks et al.|Nature Communications|2020Cited by 51
Enabling Tumor Growth and Progression: Recent Progress in Unraveling the Functions of ABL Kinases in Solid Tumor CellsR. P. Tripathi, Rina Plattner, Zulong Liu|Current Pharmacology Reports|2018Cited by 17